Global Influenza Initiative

Global Influenza Initiative Meeting

Adriana Tomic from our team presented Atomic Lab’s work on flu vaccination insights, using Artificial Intelligence (AI) at the prestigious Global Influenza Initiative (GII) by Sanofi.

The GII assembled global experts from various medical fields with a shared goal to improve understanding and prevention strategies for influenza. Their objectives are to reshape the global conversation around influenza, optimize prevention strategies, and strengthen collaboration between international stakeholders.

We felt honored to contribute to these important discussions, reinforcing our commitment to harnessing AI for the development of smarter vaccines and more effective vaccination strategies. The engaging dialogue with industry leaders like Sanofi was deeply appreciated.

 The future looks promising as we continue using advanced technology to drive us towards a healthier world.

You May Also Like…

Vaccine Congress in Glasgow

Vaccine Congress in Glasgow

Atomic lab presented its research on how AI can revolutionize vaccine development at the 17th Vaccine Congress in...